Comparative statistics by cancer registry
Table5: Comparison of 5-year absolute and relative survival of cases diagnosed between 1988-1992 and 1993-2000
(Barshi, India)Click on cancer site (ICD-10 code) for comparison
| Site | ICD-10 | 5-year absolute survival % | 5-year relative survival % | ||
| 82-91 | 92-2000 | 82-91 | 92-2000 | ||
| C01-02 | Tongue | 13.6 | 8.5 | 26.4 | 9.9 |
| C03-06 | Oral cavity | 18.7 | 21.7 | 28.1 | 23.6 |
| C12-13 | Hypopharynx | 19.9 | 8.4 | 40.1 | 11.2 |
| C15 | Oesophagus | 6.3 | 4.1 | 11.3 | 5.2 |
| C16 | Stomach | 13.3 | 4.8 | 16.9 | 6.5 |
| C19-20 | Rectum | 17.3 | 11.2 | 24.0 | 13.0 |
| C22 | Liver | 5.0 | 0.0 | 6.4 | 0.0 |
| C32 | Larynx | 19.6 | 12.7 | 36.1 | 16.1 |
| C33-34 | Lung | 14.3 | 4.6 | 20.1 | 5.2 |
| C44 | Other skin | 52.4 | 65.0 | 88.3 | 83.2 |
| C50 | Breast | 32.4 | 49.2 | 45.1 | 55.3 |
| C53 | Cervix | 28.4 | 32.2 | 37.3 | 35.1 |
| C60 | Penis | 46.7 | 44.7 | 73.8 | 58.7 |
| C82-85+C96 | Non-Hodgkin lymphoma | 8.9 | 22.2 | 11.2 | 25.4 |
| C92-94 | Myeloid leukaemia | 6.7 | 13.6 | 7.5 | 14.6 |
Graphs:
 |
Other tables available for this registry:
| - Table1: | Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Barshi, India, 1993-2000 cases followed-up until 2003) |
| - Table2a: | Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site (Barshi, India, 1993-2000 cases followed-up until 2003) |
| - Table3: | Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Barshi, India, 1993-2000 cases followed-up until 2003) |
| - Table4: | Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Barshi, India, 1993-2000 cases followed-up until 2003) |
| - Table5: | Comparison of 5-year absolute and relative survival of cases diagnosed between 1988-1992 and 1993-2000 (Barshi, India) |
Registry chapter:
 | Consult the chapter in Cancer survival in developping countries (Volume II) |